July 28 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Thursday its first-half non-consolidated net profit jumped 30.4% on the year to 33.8 million levs ($19.1 million/17.3 million euro) mainly on the back of lower costs for external services and higher financial revenues.